
RAPT Valuation
RAPT Therapeutics Inc
- Overview
- Forecast
- Valuation
- Earnings
RAPT Relative Valuation
RAPT's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, RAPT is overvalued; if below, it's undervalued.
Historical Valuation
RAPT Therapeutics Inc (RAPT) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -6.41. The fair price of RAPT Therapeutics Inc (RAPT) is between NaN to NaN according to relative valuation methord.
Relative Value
Fair Zone
NaN-NaN
Current Price:13.31
Fair
Trailing
Forward
P/E
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
1.18
P/B
Median3y
2.32
Median5y
3.32
-47.15
FCF Yield
Median3y
-51.37
Median5y
-33.59
Competitors Valuation Multiple
The average P/S ratio for RAPT's competitors is 6.63, providing a benchmark for relative valuation. RAPT Therapeutics Inc Corp (RAPT) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
People Also Watch

DMYY
DMY Squared Technology Group Inc
12.550
USD
-2.56%

INTS
Intensity Therapeutics Inc
0.325
USD
0.00%

PXS
Pyxis Tankers Inc
2.950
USD
-3.28%

BRNS
Barinthus Biotherapeutics PLC
1.790
USD
+2.58%

CALC
CalciMedica Inc
3.800
USD
+2.98%

VIVK
Vivakor Inc
0.920
USD
+14.29%

YOTA
Yotta Acquisition Corp
0
USD
+6.35%

OM
Outset Medical Inc
18.530
USD
+5.22%

TOI
Oncology Institute Inc
3.680
USD
+0.82%

MDAI
Spectral AI Inc
2.600
USD
-4.06%
FAQ

Is RAPT Therapeutics Inc (RAPT) currently overvalued or undervalued?
RAPT Therapeutics Inc (RAPT) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -6.41. The fair price of RAPT Therapeutics Inc (RAPT) is between NaN to NaN according to relative valuation methord.

What is RAPT Therapeutics Inc (RAPT) fair value?

How does RAPT's valuation metrics compare to the industry average?

What is the current P/B ratio for RAPT Therapeutics Inc (RAPT) as of Jul 26 2025?

What is the current FCF Yield for RAPT Therapeutics Inc (RAPT) as of Jul 26 2025?

What is the current Forward P/E ratio for RAPT Therapeutics Inc (RAPT) as of Jul 26 2025?
